Table 4.
Variable | B | OR (95% CI) | Pvalue |
---|---|---|---|
Age at onset | 0.025 | 1.025(0.998,1.052) | 0.068 |
Interval from onset to antifungal treatment | 0.008 | 1.008(0.998,1.018) | 0.102 |
Ventriculoperitoneal shunt placement | 1.563 | 4.775(1.168,19.524) | 0.030 |
Meningeal irritation positive | 0.851 | 2.342(0.991,5.536) | 0.052 |
CSF Glucose | -0.128 | 0.880(0.652,1.189) | 0.405 |
Meningeal enhancement | 0.602 | 1.827(0.714,4.674) | 0.209 |
GCS score | 3.129 | 22.844(2.719,191.957) | 0.004 |
Immunocompromised condition | 1.587 | 4.887(1.985,12.031) | 0.001 |
Constant | -2.147 | 0.017 |
CSF: Cerebrospinal fluid; B:Regression coefficient;OR: Odds ratio; CI: Confidence interval